← 返回

352, 783 名芬兰人中自然杀伤 (NK) 细胞 KIR 基因含量变异的疾病关联

英文原题:Disease associations of natural killer (NK) cell KIR gene content variation in 352,783 Finns.

查看英文原题

Disease associations of natural killer (NK) cell KIR gene content variation in 352,783 Finns.

PubMed 2024/11/14(内容时间) Hum Immunol Q4 · IF 2.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

编码自然杀伤(NK)细胞表面受体的KIR基因,其等位基因、基因存在/缺失和基因拷贝数变异,已在病例对照研究中被报道与感染性及自身免疫性疾病以及干细胞移植后复发相关。为更全面理解KIR基因存在/缺失变异及HLA-KIR相互作用在疾病易感性中的作用,我们基于基因组SNP数据,对FinnGen队列中10个KIR基因的存在或缺失进行基因型填补。该队列包括352,783名芬兰人,具有来自国家健康登记系统的丰富表型数据。

我们利用位于KIR基因组区段的5,900个SNP进行KIR基因基因型填补,并检验762种FinnGen表型与基因存在/缺失变异之间的关联。

我们的结果为在大型人群队列中查询HLA-KIR关联提供了平台。我们发现13种表型与KIR基因或KIR-HLA-C组合相关,错误发现率<0.05。这些结果不同于此前在FinnGen队列中报告的数量极高的HLA等位基因与疾病关联。13种显著关联中有5种涉及恶性表型,例如黑色素瘤、甲状腺肿瘤和造血系统恶性肿瘤,支持NK细胞在控制恶性肿瘤中的关键作用。

展开英文摘要原文

Allelic, gene presence/absence, and gene-copy number variations in the KIR genes encoding Natural Killer (NK) cell surface receptors have been reported to be associated in case-control studies with infectious and autoimmune diseases, and relapse after stem cell transplantation.

To understand more comprehensively the role of KIR gene presence/absence variation and HLA-KIR interactions in disease susceptibility, we imputed from genome SNP data the presence and absence of 10 KIR genes in the FinnGen cohort. The cohort consists of 352,783 Finns with extensive phenotypes from the national health registries.

We tested associations between 762 FinnGen phenotypes and presence/absence variation based on imputation of KIR genes using 5,900 SNPs located in the KIR genomic segment.

Our results provide a platform to query HLA-KIR associations in a large population cohort.

We found 13 phenotype - KIR gene or KIR - HLA C combination associations with false discovery rate < 0. 05. These results differ from the very high number of associations between HLA alleles and diseases reported earlier in the FinnGen cohort. Five of the 13 significant associations included malignant phenotypes, e. g. , melanoma, thyroid gland neoplasm, and haematopoietic malignancy, supporting the essential role of NK cells in controlling malignancy.

论文信息

作者
Ritari J、Koskela S、Hyvärinen K、FinnGen、Ollila H、Partanen J
第一作者单位
Research and Development, Finnish Red Cross Blood Service, Helsinki, Finland.Finland
通讯作者单位
Research and Development, Finnish Red Cross Blood Service, Helsinki, Finland; Blood Service Biobank, Finnish Red Cross Blood Service, Vantaa, Finland. Electronic address: jukka.partanen@veripalvelu.fi.Finland
期刊
Human immunology2024 Nov
原文标识
PubMed 39546901 · DOI 10.1016/j.humimm.2024.111177